For Patients
For Patients
For Patients
For Patients
For Patients
Recent News
Device Trial Rapid Enrollment
Tranquil Clinical Research successfully recruited and enrolled a difficult interventional device trial within two months; where the sponsor's other sites were unable to enroll in 18 months; becoming the highest enrolling clinical research unit and with 100% quality dat
continue reading
Study of COVID treatment Quellor has first patient at Louisville hospital
Tranquil is proud to announce the success of our strategic research site partner, the cardiology research team at Jewish Hospital in Louisville, KY! Dr. Naresh Solankhi & his team successfully treated the the first US patient to participate in a...
continue reading
INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial of Quellor™ for Pulmonary Complications in COVID-19 Patients
Congratulations to INmune Bio! Tranquil is proud to be a part of this tremendous effort on enrolling the first patient to this important study. LA JOLLA, Calif, Nov. 09, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”),...
continue reading
Quickest Site Activation
Tranquil Clinical Research was the fastest site activated and quickest site to enroll on a Pivotal COVID clinical trial for a top 20 Pharmaceutical Sponsor.
continue reading
Our Doctors
Dr. Joe Pouzar
Clear Lake Health
Dr. Mohamed Haq
Houston Cancer Institute
Dr. Mark Deandrea
University Cancer Center
Dr. Amir Salam
Salam Oncology Consultants
Dr. Jason Gukhool
Elite and Affinity free standing hospital
Tranquil Clinical Research provides the expertise you need from study start up to closeout and everything in between.